Pursuant to regulation 30 Part A of Schedule III of the SEBI (Listing Obligation and Disclosure Requirements) Regulation 2015, Welcure Drugs & Pharmaceuticals has informed about summary of proceedings of AGM.
The above information is a part of company’s filings submitted to BSE.